Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 11Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 11SALIX

02 2SALIX PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
American Pharma Summit
Not Confirmed

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 9326969

Drug Substance Claim :

Drug Product Claim :

Application Number : 209381

Patent Use Code : U-2310

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-09-10

blank

02

arrow
American Pharma Summit
Not Confirmed

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 9592252

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209381

Patent Use Code : U-2310

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-08-11

blank

03

arrow
American Pharma Summit
Not Confirmed

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 11529368

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209381

Patent Use Code : U-2310

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-03-09

blank

04

arrow
American Pharma Summit
Not Confirmed

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 10792306

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209381

Patent Use Code : U-2310

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-03-09

blank

05

arrow
American Pharma Summit
Not Confirmed

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 10918723

Drug Substance Claim :

Drug Product Claim :

Application Number : 209381

Patent Use Code : U-2310

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-09-10

blank

06

arrow
American Pharma Summit
Not Confirmed

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 12083179

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209381

Patent Use Code : U-2310

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-09-10

blank

07

arrow
American Pharma Summit
Not Confirmed

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 7169381

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21881

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-09-01

blank

08

arrow
American Pharma Summit
Not Confirmed

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 10780112

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209381

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-03-09

blank

09

arrow
American Pharma Summit
Not Confirmed

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 10016504

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209381

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-09-10

blank

10

arrow
American Pharma Summit
Not Confirmed

ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 10646512

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209381

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-03-25

blank